Clinical Trials Directory

Trials / Sponsors / ImmVira Pharma Co. Ltd

ImmVira Pharma Co. Ltd

Industry · 8 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Phase I/IIa Study of C5252 in Patients With Intracranial Tumor
Glioma, Malignant
Phase 1 / Phase 22025-12-15
RecruitingA Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
Nonmuscle-invasive Bladder Cancer
Phase 22025-06-09
SuspendedT3011 in Combination With Cobimetinib in Patients With Advanced Melanoma
Melanoma, Malignant Melanoma
Phase 22024-06-30
Not Yet RecruitingA Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
Solid Tumor, Glioblastoma, Glioblastoma Multiforme
Phase 12023-03-15
UnknownA Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.
Advanced Solid Tumor, Lung Cancer, Liver Cancer
Phase 1 / Phase 22022-03-01
UnknownIntravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Soli
Solid Tumor, Hepatocellular Carcinoma, Colorectal Cancer
Phase 1 / Phase 22021-08-10
RecruitingA Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous
Solid Tumor, Melanoma, HNSCC
Phase 1 / Phase 22020-09-17
UnknownA Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors
Advanced Solid Tumor, Sarcoma, HNSCC
Phase 1 / Phase 22020-04-21